NVCL-Based Galacto-Functionalized and Thermosensitive Nanogels with GNRDs for Chemo/Photothermal-Therapy.
Mirian A González-AyónJacob Licea-RodriguezEugenio R MéndezÁngel Licea-ClaveriePublished in: Pharmaceutics (2022)
Dual-function nanogels (particle size from 98 to 224 nm) synthesized via surfactant-free emulsion polymerization (SFEP) were tested as smart carriers toward synergistic chemo- and photothermal therapy. Cisplatin (CDDP) or doxorubicin (DOX) and gold nanorods (GNRDs) were loaded into galacto-functionalized PNVCL-based nanogels, where the encapsulation efficiency for CDDP and DOX was around 64 and 52%, respectively. PNVCL-based nanogels were proven to be an efficient delivery vehicle under conditions that mimic the tumor site in vitro. The release of CDDP or DOX was slower at pH 7.4 and 37 °C than at tumor conditions of pH 6 and 40 °C. On the other hand, in the systems with GNRDs at pH 7.4 and 37 °C, the sample was irradiated with a 785 nm laser for 10 min every hour, obtaining that the release profiles were even higher than in the conditions that simulated a cancer tissue (without irradiation). Thus, the present study demonstrates the synergistic effect of chemo- and photothermal therapy as a promising dual function in the potential future use of PNVCL nanogels loaded with GNRDs and CDDP/DOX to achieve an enhanced chemo/phototherapy in vivo.
Keyphrases
- cancer therapy
- photodynamic therapy
- drug delivery
- locally advanced
- quantum dots
- blood pressure
- papillary thyroid
- squamous cell carcinoma
- molecularly imprinted
- current status
- mass spectrometry
- radiation induced
- gold nanoparticles
- radiation therapy
- high resolution
- squamous cell
- climate change
- rectal cancer
- young adults
- simultaneous determination
- childhood cancer